Mesquite Diagnostics Imaging Mesquite, TX - 75150

Mesquite Diagnostics Imaging is categorized under Clinics in Mesquite, TX .

Mesquite Diagnostics Imaging was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6215120 by the NAICS.

If you are seeking more information, feel free to contact Kym Tayamen, Director at the company’s single location by writing to 2540 North Galloway Avenue # 207, Mesquite, Texas TX 75150 or by phoning (972) 686-1944. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mesquite Diagnostics Imaging
Contact Person: Kym Tayamen, Director
Address: 2540 North Galloway Avenue # 207, Mesquite, Texas 75150
Phone Number: (972) 686-1944
Website Address: dallasregionalmedicalcenter.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Clinics
SIC Code: 8011
NAICS Code: 6215120
Share This Business:

Mesquite Diagnostics Imaging was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6215120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Kym Tayamen, Director for inquiries that concern Mesquite Diagnostics Imaging by calling the company number (972) 686-1944, as your correspondence is most welcome. Additionally, the physical location of the single location of Mesquite Diagnostics Imaging can be found at the coordinates 32.799545,-96.611436 as well as the street address 2540 North Galloway Avenue # 207 in Mesquite, Texas 75150.

For its online presence, you may visit Mesquite Diagnostics Imaging’s website at dallasregionalmedicalcenter.com and engage with its social media outlets through on Twitter and on Facebook.